期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

1％吡美莫司乳膏治疗剥脱性唇炎疗效观察 被引量：3

原文传递
导出
摘要 剥脱性唇炎的确切病因和发病机制尚不清楚，临床上缺乏比较有效的治疗方法和药物。我们采用1％吡美莫司乳膏外用治疗剥脱性唇炎，获得了满意的疗效。
作者 陈昭 陈峥 黄科宇 康康
机构地区 河北省唐山市工人医院 河北省唐山市人民医院 河北省开滦总医院
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2015年第9期654-655,共2页 Chinese Journal of Dermatology
关键词 剥脱性唇炎 疗效观察 吡美莫司 治疗方法 乳膏 发病机制 外用治疗
分类号 R781.56 [医药卫生—口腔医学]
  • 相关文献

参考文献5

  • 1Hoetzenecker W, Meingassner JG, Ecker R, et al. Corticosteroids but not pimecrolimus affect viability, maturation and immune function of murine epidermal Langerhans cells[J]. J Invest Dermatol, 2004, 122 (3): 673-684.
  • 2Kalthoff FS, Chung J, Musser P, et al. Pimecrolimus does not affect the differentiation, maturation and function of human monoeyte- derived dendritic ceils, in contrast to corticosteroids [J]. Clin Exp Immunol, 2003, 133(3): 350-359.
  • 3Hultsch T, Kapp A, Spergel J. Immunomodulation and safety of topical ealeineurin inhibitors for the treatment of atopic dermatitis [J]. Dermatology, 2005, 211(2): 174-187.
  • 4王文慧,李邻峰.吡美莫司在特应性皮炎中的应用[J].中华皮肤科杂志,2006,39(11):678-680. 被引量：7
  • 5Almazrooa SA, Woo SB, Mawardi H. Characterization and manage- ment of exfoliative cheilitis: a single-center experience[ J ]. Oral Surg Oral Med Oral Pathol Oral Radio1, 2013, 116 (6): e485-489.

二级参考文献23

  • 1Queille-Roussel C,Paul C,Duteil L,et al.The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks:a randomized,double-blind controlled study.Br J Dermatol,2001,144:507-513.
  • 2Papp KA,Breuer K,Meurer M,et al.Long-term treatment of atopic dermatitis with pimecrolimus cream 1% in infants does not interfere with the development of protective antibodies after vaccination.J Am Acad Dermatol,2005,52:247-253.
  • 3Rappersberger K,Komar M,Ebelin ME,et al.Pimecrolimus identifies a common genomic anti-inflammatory profile,is clinically highly effective in psoriasis and is well tolerated.J Invest Dermatol,2002,119:876-877.
  • 4Fonacier L,Spergel J,Charlesworth EN,et al.Report of the Topical Calcineurin Inhibitor Task Force of the American College of Allergy,Asthma and Immunology and the American Academy of Allergy,Asthma and Immunology.J Allergy Clin Immunol,2005,115:1249-1253.
  • 5Eichenfield LF,Beck L.Elidel (pimecrolimus) cream 1%:a nonsteroidal topical agent for the treatment of atopic dermatitis.J Allergy Clin Immunol,2003,111:1153-1168.
  • 6Billich A,Aschauer H,Aszodi A,et al.Percutaneous absorption of drugs used in atopic eczema:pimecrolimus permeates less through skin than corticosteroids and tacrolimus.Int J Pharm,2004,269:29-35.
  • 7Meingassner JG,Aschauer H,Stuetz A,et al.Pimecrolimus permeates less than tacrolimus through normal,inflamed,or corticosteroid-pretreated skin.Exp Dermatol,2005,14:752-757.
  • 8Van Leent EJ,Ebelin ME,Burtin P,et al.Low systemic exposure after repeated topical application of Pimecrolimus (Elidel,SDZ ASM 981) in patients with atopic dermatitis.Dermatology,2002,204:63-68.
  • 9Allen BR,Lakhanpaul M,Morris A,et al.Systemic exposure,tolerability,and efficacy of pimecrolimus cream 1% in atopic dermatitis patients.Arch Dis Child,2003,88:969-973.
  • 10Staab D,Pariser D,Gottlieb AB,et al.Low systemic absorption and good tolerability of pimecrolimus,administered as 1% cream (Elidel) in infants with atopic dermatitis-a multicenter,3-week,open-label study.Pediatr Dermatol,2005,22:465-471.

共引文献6

同被引文献14

引证文献3

二级引证文献3

中华皮肤科杂志
2015年 第9期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部